Improving Clinical Islet Transplantation Outcomes-Reference-Cited by-同舟云学术

Improving Clinical Islet Transplantation Outcomes

Published:2020-03-12 Issue:4 Volume:43 Page:698-700
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Roep Bart O.¹²^ORCID

Affiliation:

1. Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

2. Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/43/4/698/532983/dci190080.pdf

Reference21 articles.

1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen;Shapiro;N Engl J Med,2000

2. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia;Hering;Diabetes Care,2016

3. The challenge of modulating β-cell autoimmunity in type 1 diabetes;Atkinson;Lancet Diabetes Endocrinol,2019

4. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes;Hering;JAMA,2005

5. Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft;Keymeulen;Proc Natl Acad Sci U S A,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics;Clinical and Translational Medicine;2023-06-29

2. The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes;Frontiers in Immunology;2023-01-17

3. BMSCs overexpressed ISL1 reduces the apoptosis of islet cells through ANLN carrying exosome, INHBA, and caffeine;Cellular and Molecular Life Sciences;2022-10

4. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes;Acta Biomaterialia;2021-10

5. Optical Nanosensors for Real‐Time Feedback on Insulin Secretion by β‐Cells;Small;2021-07